Clinical Trial Update: Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure Unit [Phase 4]

View source ↗

Summary

Phase 4 randomized, double-blind trial comparing single-dose fexofenadine HCl 180 mg to montelukast Na 10 mg and placebo for onset of action, efficacy, and safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Fexofenadine HCl 180 mg (fexofenadine)
• Montelukast Na 10 mg (montelukast)

Snippet

Sponsor: Sanofi | Conditions: Seasonal Allergic Rhinitis | Phase 4 | Status: COMPLETED